CClinicalTrials.gg
CompletedNCT01984671Updated Oct 28, 2025Results posted

mPCST for BMT Patients

An interventional study of Mobile Pain Coping Skills Training in Stem Cell Transplant, sponsored by Duke University. Completed at 1 site in United States. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2025-10-28.

Sponsored by Duke University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
21 Years and older
Sex
All
01

Study summary

We used a small randomized controlled trial (n=36) to compare a Mobile Health Pain Coping Skills (mPCST) to Usual Treatment for patients having received hematopoietic stem cell transplant.

Read the detailed description

The investigator proposes to develop and test a Mobile Health Pain Coping Skills (mPCST) protocol for HSCT patients with persistent pain to meet the challenges of HSCT patients with pain as they transition from hospital based care to their home environment. We used a small randomized controlled trial to examine the feasibility and acceptability, and engagement in the developed mPCST protocol. We compared the effects of usual care to the developed mPCST protocol on pain disability, pain self-efficacy, fatigue, and physical disability.

02

Conditions studied

  • Stem Cell Transplant
03

In context

Lead sponsor

Duke University is the lead sponsor of 2,025 studies on the registry; 275 are open to participants now.

Of its 194 completed or terminated interventional studies of FDA-regulated products, 159 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  1. receipt of an stem cell transplant due to an oncological disease,
  2. no prior stem cell transplant,
  3. report a clinical pain score of at least 3/10, and
  4. an age of > 21.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
36 participants (actual)

Study arms

  • Experimental
    Mobile pain coping skills training (mPCST)

    Participants in this condition completed the first session following their baseline survey assessment. The developed mPCST protocol included 1 in-person session at the medical center between the patient and study therapist, which led to the development of a successful working relationship and the integration of mPCST with the patient's medical care. Then, once the patient returned home following intensive outpatient care, 5 more sessions were conducted using videoconferencing. Last, participants completed the post-assessment.

    Behavioral: Mobile Pain Coping Skills Training

  • No intervention
    Usual care control

    Patients in this condition will have access to activity tracker syncing and daily symptoms assessment following their baseline survey assessment. HCT education participants will be encouraged to download the Transplant (HCT) Guidelines mobile app that is free of charge. Last, participants completed the post-assessment.

Interventions

  • BehavioralMobile Pain Coping Skills Training
06

What researchers measure

Primary outcomes

  1. Feasibility as Measured by the Overall Percentage of Completed Sessions

    Presented as the (total number of completed sessions for all participants) divided by the (total number of planned sessions for all participants) multiplied by 100. The goal of this study was to develop a PCST intervention that could be used to enhance the ability of HCT patients to manage their pain following transplant, that is feasible and acceptable.

    Time frame: 10 weeks

  2. Acceptability as Measured by the Percentage of Participants Who Responded in the Affirmative for Each Item on the Assessment

    The goal of this study was to develop a PCST intervention that could be used to enhance the ability of HCT patients to manage their pain following transplant, that is feasible and acceptable.

    Time frame: 10 weeks

Secondary outcomes

  1. Cohen's D Effect Size of the Change in Pain Disability From Baseline to 10 Weeks

    A positive value indicates improvement in pain disability and a negative value indicates a decline.

    Time frame: Baseline to 10 weeks

  2. Cohen's D Effect Size of the Change in Pain Self-efficacy From Baseline to 10 Weeks

    A positive value indicates improvement in pain self-efficacy and a negative value indicates a decline.

    Time frame: Baseline to 10 weeks

  3. Cohen's D Effect Size of the Change in Fatigue From Baseline to 10 Weeks

    A positive value indicates improvement in pain self-efficacy and a negative value indicates a decline.

    Time frame: Baseline to 10 weeks

  4. Cohen's D Effect Size of the Change in 2-minute Walk Test From Baseline to 10 Weeks

    A positive value indicates improvement in the 2-minute walk test and a negative value indicates a decline.

    Time frame: Baseline to 10 weeks

07

Results

Posted Oct 28, 2025

Participant flow

Participant flow — Overall Study
MilestoneMobile Pain Coping Skills Training (mPCST)Usual Care Control
Started1818
Completed1617
Not completed21

Outcome measures

PrimaryFeasibility as Measured by the Overall Percentage of Completed Sessions

Presented as the (total number of completed sessions for all participants) divided by the (total number of planned sessions for all participants) multiplied by 100. The goal of this study was to develop a PCST intervention that could be used to enhance the ability of HCT patients to manage their pain following transplant, that is feasible and acceptable.

Time frame:
10 weeks
Reported as:
Number · percentage of sessions
Feasibility as Measured by the Overall Percentage of Completed Sessions
percentage of sessionsMobile Pain Coping Skills Training (mPCST)Usual Care Control
Feasibility as Measured by the Overall Percentage of Completed Sessions83—
SecondaryCohen's D Effect Size of the Change in Pain Disability From Baseline to 10 Weeks

A positive value indicates improvement in pain disability and a negative value indicates a decline.

Time frame:
Baseline to 10 weeks
Reported as:
Number · Cohen's d
Cohen's D Effect Size of the Change in Pain Disability From Baseline to 10 Weeks
Cohen's dMobile Pain Coping Skills Training (mPCST)Usual Care Control
Cohen's D Effect Size of the Change in Pain Disability From Baseline to 10 Weeks0.790.69
PrimaryAcceptability as Measured by the Percentage of Participants Who Responded in the Affirmative for Each Item on the Assessment

The goal of this study was to develop a PCST intervention that could be used to enhance the ability of HCT patients to manage their pain following transplant, that is feasible and acceptable.

Time frame:
10 weeks
Reported as:
Number · percentage of participants
Acceptability as Measured by the Percentage of Participants Who Responded in the Affirmative for Each Item on the Assessment
percentage of participantsMobile Pain Coping Skills Training (mPCST)Usual Care Control
Helpful (reported in assessment)80—
Easy to understand (reported in assessment)100—
Acceptable (reported in assessment)100—
SecondaryCohen's D Effect Size of the Change in Pain Self-efficacy From Baseline to 10 Weeks

A positive value indicates improvement in pain self-efficacy and a negative value indicates a decline.

Time frame:
Baseline to 10 weeks
Reported as:
Number · Cohen's d
Cohen's D Effect Size of the Change in Pain Self-efficacy From Baseline to 10 Weeks
Cohen's dMobile Pain Coping Skills Training (mPCST)Usual Care Control
Cohen's D Effect Size of the Change in Pain Self-efficacy From Baseline to 10 Weeks0.610.10
SecondaryCohen's D Effect Size of the Change in Fatigue From Baseline to 10 Weeks

A positive value indicates improvement in pain self-efficacy and a negative value indicates a decline.

Time frame:
Baseline to 10 weeks
Reported as:
Number · Cohen's d
Cohen's D Effect Size of the Change in Fatigue From Baseline to 10 Weeks
Cohen's dMobile Pain Coping Skills Training (mPCST)Usual Care Control
Cohen's D Effect Size of the Change in Fatigue From Baseline to 10 Weeks0.940.81
SecondaryCohen's D Effect Size of the Change in 2-minute Walk Test From Baseline to 10 Weeks

A positive value indicates improvement in the 2-minute walk test and a negative value indicates a decline.

Time frame:
Baseline to 10 weeks
Reported as:
Number · Cohen's d
Cohen's D Effect Size of the Change in 2-minute Walk Test From Baseline to 10 Weeks
Cohen's dMobile Pain Coping Skills Training (mPCST)Usual Care Control
Cohen's D Effect Size of the Change in 2-minute Walk Test From Baseline to 10 Weeks0.660.41

Adverse events

Collected over 10 weeks. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Mobile Pain Coping Skills Training (mPCST)0/18 (0%)0/18 (0%)0/18 (0%)
Usual Care Control0/18 (0%)0/18 (0%)0/18 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Mobile Pain Coping Skills Training (mPCST)Usual Care ControlTotal
<=18 years000
Between 18 and 65 years131326
>=65 years5510
Age, Continuous
Age, Continuous(years)Mobile Pain Coping Skills Training (mPCST)Usual Care ControlTotal
Mean54.6 (29 to 70)57.9 (40 to 75)56.25 (29 to 75)
Sex: Female, Male
Sex: Female, Male(Participants)Mobile Pain Coping Skills Training (mPCST)Usual Care ControlTotal
Female11718
Male71118
Region of Enrollment
Region of Enrollment(Participants)Mobile Pain Coping Skills Training (mPCST)Usual Care ControlTotal
United States181836
08

Study locations

1 site
  • Duke University Medical Center
    Durham, North Carolina 27708, United States
09

References and documents

Publications

  • Somers TJ, Kelleher SA, Dorfman CS, Shelby RA, Fisher HM, Rowe Nichols K, Sullivan KM, Chao NJ, Samsa GP, Abernethy AP, Keefe FJ. An mHealth Pain Coping Skills Training Intervention for Hematopoietic Stem Cell Transplantation Patients: Development and Pilot Randomized Controlled Trial. JMIR Mhealth Uhealth. 2018 Mar 19;6(3):e66. doi: 10.2196/mhealth.8565. PubMed 29555620 ↗
10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 28, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01984671
Lead sponsor
Duke University
Responsible party
Sponsor
First posted
Nov 15, 2013
Start date
Oct 2, 2013
Primary completion
Dec 1, 2015
Completion
Dec 1, 2015
Results posted
Oct 28, 2025
Last update
Oct 28, 2025

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion